Core Viewpoint - The stock of Elon Technology (688329) has experienced a decline, with a closing price of 26.54 yuan on February 24, 2026, down by 3.03% [1] Group 1: Stock Performance - On February 24, 2026, the trading volume was 26,700 hands, with a total transaction amount of 71.32 million yuan [1] - The net outflow of main funds was 1.47 million yuan, accounting for 2.06% of the total transaction amount [1] - Retail investors saw a net outflow of 4.79 million yuan, representing 6.72% of the total transaction amount, while speculative funds had a net inflow of 6.26 million yuan, making up 8.78% of the total transaction amount [1] Group 2: Financing and Margin Trading - On the same day, the financing buy amounted to 6.84 million yuan, while financing repayment was 5.21 million yuan, resulting in a net financing increase of 1.62 million yuan [2] - There were no shares sold or repaid in the margin trading segment, with a margin balance of 0.00 yuan [2] - The total balance of financing and margin trading stood at 50.71 million yuan [2] Group 3: Financial Performance - For the first three quarters of 2025, Elon Technology reported a main revenue of 280 million yuan, an increase of 25.12% year-on-year [3] - The net profit attributable to shareholders was -0.96 million yuan, showing a significant improvement of 96.56% year-on-year [3] - The third quarter of 2025 alone saw a main revenue of 149 million yuan, up by 83.53% year-on-year, with a net profit of 7.43 million yuan, reflecting a year-on-year increase of 182.09% [3] - The company reported a debt ratio of 42.74% and a gross profit margin of 45.79% [3]

Group 1 - The core viewpoint of the news is that Ailong Technology (688329) has shown significant growth in its revenue and net profit for the third quarter of 2025, indicating a positive trend in its financial performance [2]. - As of February 9, 2026, Ailong Technology's stock closed at 26.02 yuan, with a 1.64% increase and a trading volume of 16,700 hands, amounting to a total transaction value of 43.35 million yuan [1]. - The company reported a main business revenue of 280 million yuan for the first three quarters of 2025, representing a year-on-year increase of 25.12% [2]. Group 2 - In the third quarter of 2025, Ailong Technology achieved a single-quarter main business revenue of 149 million yuan, which is an 83.53% year-on-year increase [2]. - The net profit attributable to the parent company for the first three quarters was -959,000 yuan, but this reflects a 96.56% year-on-year improvement [2]. - The company specializes in intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for medical service institutions [2].

Group 1 - The core stock price of Elon Technology (688329) closed at 25.24 yuan on February 2, 2026, with an increase of 0.92% and a turnover rate of 4.38% [1] - The trading volume was 33,800 hands, with a total transaction amount of 87.12 million yuan [1] - The net inflow of main funds was 4.45 million yuan, accounting for 5.11% of the total transaction amount, while retail investors had a net outflow of 4.75 million yuan, accounting for 5.45% [1] Group 2 - In the financing and securities lending data, the financing buy amounted to 8.79 million yuan, with a net financing buy of 1.37 million yuan [2] - The total balance of financing and securities lending was 46.24 million yuan [2] Group 3 - For the first three quarters of 2025, Elon Technology reported a main revenue of 280 million yuan, a year-on-year increase of 25.12% [3] - The net profit attributable to the parent company was -0.96 million yuan, showing a year-on-year increase of 96.56% [3] - The gross profit margin was 45.79%, with a debt ratio of 42.74% [3] - The company focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms [3]

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Ailong Technology (688329), indicating a slight decline in stock price and mixed capital flow on January 29, 2026 [1][2] - Ailong Technology reported a main revenue of 280 million yuan for the first three quarters of 2025, reflecting a year-on-year increase of 25.12% [2] - The company experienced a net profit attributable to shareholders of -959,000 yuan, which is an improvement of 96.56% year-on-year [2] Group 2 - In Q3 2025, Ailong Technology achieved a single-quarter main revenue of 149 million yuan, marking an impressive year-on-year increase of 83.53% [2] - The net profit attributable to shareholders for Q3 2025 was 7.43 million yuan, showing a significant year-on-year increase of 182.09% [2] - The company operates in the field of intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [2]

Core Viewpoint - Ailong Technology (688329) reported a revenue increase of 25.12% year-on-year for the first three quarters of 2025, indicating strong growth in the medical supplies management sector [2]. Financial Performance - For the first three quarters of 2025, Ailong Technology achieved a main business revenue of 280 million yuan, with a net profit attributable to shareholders of -959,000 yuan, an improvement of 96.56% year-on-year [2]. - The third quarter of 2025 saw a single-quarter main business revenue of 149 million yuan, reflecting an 83.53% year-on-year increase, and a net profit attributable to shareholders of 7.43 million yuan, up 182.09% year-on-year [2]. - The company reported a gross profit margin of 45.79% and a debt ratio of 42.74% [2]. Market Activity - As of January 28, 2026, Ailong Technology's stock closed at 24.27 yuan, down 0.37%, with a turnover rate of 1.53% and a trading volume of 11,800 hands, amounting to a transaction value of 28.73 million yuan [1]. - The net outflow of main funds was 1.0035 million yuan, accounting for 3.49% of the total transaction value, while retail investors saw a net inflow of 3.43 million yuan, representing 11.94% of the total transaction value [1].

Core Viewpoint - The stock of Elon Technology (688329) has shown a significant increase, closing at 23.03 yuan on January 5, 2026, with an 8.17% rise, indicating positive market sentiment towards the company [1]. Financial Performance - For the first three quarters of 2025, Elon Technology reported a main revenue of 280 million yuan, reflecting a year-on-year increase of 25.12% [3]. - The net profit attributable to shareholders was -959,000 yuan, which represents a year-on-year improvement of 96.56% [3]. - The company's net profit excluding non-recurring items was -11.47 million yuan, showing a year-on-year increase of 66.35% [3]. - In Q3 2025, the company achieved a single-quarter main revenue of 149 million yuan, up 83.53% year-on-year [3]. - The single-quarter net profit attributable to shareholders was 7.43 million yuan, marking a year-on-year increase of 182.09% [3]. - The single-quarter net profit excluding non-recurring items was 6.62 million yuan, up 160.26% year-on-year [3]. - The company's debt ratio stands at 42.74%, with investment income reported at -4.25 million yuan and financial expenses at 4.69 million yuan [3]. - The gross profit margin is recorded at 45.79% [3]. Market Activity - On January 5, 2026, the net inflow of main funds was 221,000 yuan, accounting for 0.33% of the total transaction amount [1]. - Retail investors experienced a net outflow of 1.23 million yuan, representing 1.83% of the total transaction amount [1]. - The financing data indicates a financing buy of 6.51 million yuan and a financing repayment of 2.40 million yuan, resulting in a net financing buy of 4.10 million yuan [2]. - The total balance of financing and securities lending stands at 46.81 million yuan [2].

Core Viewpoint - Ailong Technology (688329) reported a stock price of 21.07 yuan as of December 23, 2025, reflecting a decrease of 2.59% with a trading volume of 12,500 shares and a total transaction amount of 26.56 million yuan [1] Group 1: Financial Performance - For the first three quarters of 2025, Ailong Technology achieved a main revenue of 280 million yuan, representing a year-on-year increase of 25.12% [3] - The net profit attributable to shareholders was -959,000 yuan, showing a year-on-year improvement of 96.56% [3] - The third quarter of 2025 saw a single-quarter main revenue of 149 million yuan, up 83.53% year-on-year, with a net profit of 7.43 million yuan, an increase of 182.09% year-on-year [3] - The company reported a gross margin of 45.79% and a debt ratio of 42.74% [3] Group 2: Capital Flow - On December 23, 2025, the net outflow of main funds was 1.563 million yuan, accounting for 5.88% of the total transaction amount, while retail investors experienced a net outflow of 1.768 million yuan, representing 6.66% of the total [1] - The financing data indicated a net purchase of 638,700 yuan on the same day, with total financing and margin balance at 52.68 million yuan [2]

Group 1 - The core viewpoint of the news is that Ailong Technology (688329) has shown a significant increase in revenue and net profit in the third quarter of 2025, indicating positive growth despite a net loss in the first three quarters [2] - Ailong Technology's main business focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [2] - The company's revenue for the first three quarters of 2025 reached 280 million yuan, a year-on-year increase of 25.12%, while the net profit attributable to shareholders was a loss of 959,000 yuan, but this represented a year-on-year improvement of 96.56% [2] Group 2 - In the third quarter of 2025, Ailong Technology reported a single-quarter revenue of 149 million yuan, which is an 83.53% year-on-year increase, and a net profit of 7.43 million yuan, reflecting a year-on-year increase of 182.09% [2] - The company's debt ratio stands at 42.74%, with investment income recorded at a loss of 4.25 million yuan and financial expenses amounting to 4.69 million yuan, while the gross profit margin is 45.79% [2] - The capital flow data on December 9, 2025, indicates a net outflow of 987,800 yuan from main funds, accounting for 6.33% of the total transaction amount, while retail funds saw a net inflow of 1.81 million yuan, representing 11.61% of the total transaction amount [1]

Core Viewpoint - On November 21, Ailong Technology experienced a decline of 4.95% with a trading volume of 48.73 million yuan, indicating a potential market reaction to recent financial performance and investor sentiment [1] Financing Summary - On the same day, Ailong Technology had a financing purchase amount of 7.44 million yuan and a financing repayment of 2.52 million yuan, resulting in a net financing purchase of 4.91 million yuan [1] - As of November 21, the total financing and securities lending balance for Ailong Technology was 57.79 million yuan, which accounts for 3.51% of its market capitalization, indicating a low financing balance compared to the 20th percentile over the past year [1] - There were no shares repaid or sold in the securities lending market on November 21, with a total securities lending balance of 0.00 yuan, suggesting a high level of inactivity in this area compared to the 90th percentile over the past year [1] Company Overview - Ailong Technology, established on January 20, 2006, and listed on March 29, 2021, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [2] - The company's revenue composition includes: smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [2] - As of September 30, the number of shareholders was 5,144, a decrease of 4.99%, while the average circulating shares per person increased by 5.25% to 15,007 shares [2] Financial Performance - For the period from January to September 2025, Ailong Technology reported a revenue of 280 million yuan, reflecting a year-on-year growth of 25.12%, while the net profit attributable to the parent company was -0.96 million yuan, showing a significant year-on-year improvement of 96.56% [2] Dividend Information - Since its A-share listing, Ailong Technology has distributed a total of 111 million yuan in dividends, with 49.05 million yuan distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, the sixth largest circulating shareholder of Ailong Technology was the Dacheng CSI 360 Internet + Index A (002236), holding 741,700 shares, which is a decrease of 86,500 shares compared to the previous period [3]

Group 1 - The core point of the news is that Ailong Technology's stock price has dropped by 5.04%, currently trading at 21.31 CNY per share, with a total market capitalization of 1.645 billion CNY [1] - Ailong Technology, established on January 20, 2006, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [1] - The company's main revenue sources include smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories [1] Group 2 - Among Ailong Technology's top circulating shareholders, Dacheng Fund's index fund has reduced its holdings by 86,500 shares, now holding 741,700 shares, which is 0.96% of the circulating shares [2] - The Dacheng Zhongzheng 360 Internet + Index A fund has achieved a year-to-date return of 38.22% and a one-year return of 39.52%, ranking 871 out of 4208 and 577 out of 3972 respectively [2]